SC 13D

Company

Ernexa Therapeutics Inc.

Filed

November 21, 2018

Accession Number

0001062993-18-004781

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →